RP HPLC method development and validation for simultaneous determination of trifluridine and tipiracil in pure and tablet dosage form

RP HPLC method development and validation for simultaneous determination of trifluridine and tipiracil in pure and tablet dosage form

Authors

  • RV. Valli Kumari Department of Pharmaceutical Analysis, Malla Reddy Institute of Pharmaceutical sciences, Maisammaguda, Dhulapally, Secundrabad -500014,Telangana State, India.
  • G. Vardhani Department of Pharmaceutical Analysis, Malla Reddy Institute of Pharmaceutical sciences, Maisammaguda, Dhulapally, Secundrabad -500014,Telangana State, India.

DOI:

https://doi.org/10.61096/ijpar.v8.iss3.2019.377-386

Keywords:

Trifluridine, Tipiracil, RP-HPLC, Validation.

Abstract

In this research, Lonsurf Tablets (strength:Trifluridine 20mg and Tipiracil 8.19mg) was investigated for trifluridine and tipiracil content by isocratic RP-HPLC Procedure. Potent separation with reproducible resolution of trifluridine and tipiracil was brought using acetonitrile (35%) and 0.1M dipotassium hydrogen phosphate (65%) at 1.0ml/min rate of flow. 10 µl and 265 nm are the sample injection volume and wavelength set for detection and analysis , respectively. The procedure was validated and favourable linearity of Trifluridine (10 to 30 µg/ml) and Tipiracil (4.095 to 12.285 µg/ml) was achieved with regression coefficient of 0.9999 and 0.9998, respectively. The proposed procedure of RP-HPLC proved to be suitable, rapid, accurate, precise, selective and robust for partition and assessment of Trifluridine and Tipiracil in tablets in quality control labs.

Downloads

Published

2022-09-13

How to Cite

RV. Valli Kumari, & G. Vardhani. (2022). RP HPLC method development and validation for simultaneous determination of trifluridine and tipiracil in pure and tablet dosage form. International Journal of Pharmacy and Analytical Research, 8(3), 377–386. https://doi.org/10.61096/ijpar.v8.iss3.2019.377-386